Immunology / Psoriasis

Indication

Psoriasis

Assets addressing this indication.

Total attributable cost

$87.4B

$11,062/patient

Drug spend

Not yet sourced

How this is calculated ↗

All severities, physician-diagnosed history (2023 NHIS) · US